Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2014 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (420)	11/9/2014 11:36:39 PM
From: technetium	Read Replies (2) \| Respond to of 487

LabCorp to buy Covance dealbook.nytimes.com "Under the terms of the deal, LabCorp [LH] will pay $105.12 a share, nearly 32 percent higher than the close of Covance shares on Friday. Covance shareholders will receive $75.76 in cash and 0.2686 of a LabCorp share for each share they own. They will own about 15.5 percent of the combined company." This news is followed by announcements from a variety of law firms launching investigations of CVD over its proposed sale to Laboratory Corp. of America Holdings for $5.6 billion. Unhappy campers. I don't know if this can/will delay or alter this sale. "The investigation focuses on whether Covance's Board of Directors breached their fiduciary duties to the Company's stockholders by failing to conduct a fair sales process and whether and by how much this proposed transaction undervalues the Company to the detriment of Covance's shareholders." finance.yahoo.com

To: BulbaMan who wrote (420)	11/14/2014 4:53:17 PM
From: BulbaMan	1 Recommendation Recommended By rkrw Read Replies (1) \| Respond to of 487

11/14/14 Contest update Biotechs were headed for a small weekly gain when they succumbed to the “Friday the 14th” hex. And when they rang the closing bell, both the Contest median, now up 3.98% YTD (vs. up 4.50% YTD a week ago) and the larger-cap Nasdaq Biotech Index, now up 27.24% YTD (vs. up 28.15% YTD a week ago) wound up down a bit for the week. The Nasdaq Composite Index, however, managed a small weekly gain, closing up 12.26% YTD (vs. up 10.92% YTD a week ago). Clearly, there was no jinxing of DEWDIL’s portfolio this week as it vaulted into the Contest lead with a 90.01% YTD gain! DIEGO’s portfolio, up 85.15% YTD, slipped to second place, while WATCHIT’s portfolio, up 73.65% YTD, held third place. At Friday's close, 28 of the 46 Contest portfolios were in the black, while 12 of the 46 beat the NBI. The median Contest portfolio stock (KARO.ST) is down -8.22% YTD. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week. (Prices not converted to US$ in these Tables.) Portfolio adjustments: DVAX 1-10 reverse split (All corrections, especially adjustments for splits, greatly appreciated.) Have a safe & fun weekend biotechies! Peace & good health, Bulba 11/14/14 Rank Name Profit/Loss 1 DEWDIL 90,009 2 DIEGO 85,150 3 WATCHIT 73,648 4 DOUGH 69,774 5 STEVEL 59,553 6 PGO 48,280 7 TECHNET 34,159 8 MCBIO 33,006 9 GHMM 32,176 10 ROCKY 30,674 Week's Top 5 Gainers Symbol 11/7 11/14 Wk.%chg. OREX 3.85 5.65 46.75% ACHN 10.11 13.97 38.13% CYTN.SW 0.16 0.21 31.25% TGTX 11.27 14.03 24.49% ZIOP 3.14 3.73 18.79% Week's Worst 5 Losers Symbol 11/7 11/14 Wk.%chg. RGLS 22.08 17.20 -22.10% ICO.V 0.05 0.04 -20.00% ABIO 1.02 0.89 -12.72% MRNA 0.92 0.81 -12.54% VCYT 7.73 6.77 -12.42%